ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,411Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1290

$1.33M Total Retail Price of All Prescriptions

Rank: 24 out of 1290

1,117 Patients Receiving at Least One Drug in Part D
23%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,117 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 3,157 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
TRAZODONE HCL 1,405 273 1 44
CITALOPRAM HBR 1,351 287 2 29
RISPERIDONE 885 115 3 68
ALPRAZOLAM 741 190 4 47
ZOLPIDEM TARTRATE 729 99 5 15
QUETIAPINE FUMARATE 674 94 6 80
FLUOXETINE HCL 660 129 7 79
GABAPENTIN 616 53 8 8
SERTRALINE HCL 542 118 9 36
CARBAMAZEPINE 540 64 10 10 191
BENZTROPINE MESYLATE 509 51 R 11 108
LAMOTRIGINE 483 102 12 100
FLUPHENAZINE HCL 385 63 10 13 294
PAROXETINE HCL 384 91 14 84
DIVALPROEX SODIUM 348 30 15 121
CYMBALTA 306 58 16 59
ABILIFY 301 27 17 114
SEROQUEL 295 37 18 186
LORAZEPAM 285 47 19 132
OLANZAPINE 277 23 20 169
LITHIUM CARBONATE 277 36 20 223
ESCITALOPRAM OXALATE 270 45 22 63
BUPROPION HCL SR 251 29 23 187
BUSPIRONE HCL 249 44 24 178
PERPHENAZINE 231 52 25 340
TOPIRAMATE 227 17 26 91
BUPROPION XL 220 27 27 143
TEMAZEPAM 209 31 28 71
AMPHETAMINE SALT COMBO 209 18 S2 28 317
VENLAFAXINE HCL ER 199 48 30 154
OXCARBAZEPINE 199 19 30 228
MIRTAZAPINE 192 56 32 93
HYDROXYZINE PAMOATE 188 37 R 33 222
AMITRIPTYLINE HCL 188 36 R 33 97
ZIPRASIDONE HCL 139 0 35 253
DIAZEPAM 134 18 36 261
DOXEPIN HCL 129 44 37 325
HALOPERIDOL 128 18 38 204
CHLORPROMAZINE HCL 120 25 39 380
SEROQUEL XR 115 11 40 151
DONEPEZIL HCL 115 87 40 13
CLOZAPINE 111 0 42 264
CLONAZEPAM 108 36 43 170
TRIHEXYPHENIDYL HCL 105 0 R 44 298
DIVALPROEX SODIUM ER 104 17 45 197
FLUPHENAZINE DECANOATE 93 12 46 438
METHYLPHENIDATE HCL 89 20 47 460
LEXAPRO 77 14 48 173
VENLAFAXINE HCL 77 19 48 327
THIOTHIXENE 73 28 50 555
THIORIDAZINE HCL 70 21 R 51 567
NORTRIPTYLINE HCL 67 27 52 269
LISINOPRIL 58 0 53 5
OMEPRAZOLE 52 14 54 2
SIMVASTATIN 52 14 54 1
BUPROPION HCL 51 0 56 379
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.